Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pacira BioSciences, Inc. - Common Stock
(NQ:
PCRX
)
24.65
+0.18 (+0.74%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pacira BioSciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
October 12, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
October 10, 2023
From
Pacira BioSciences
Via
GlobeNewswire
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
October 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Leadership Succession Plan
September 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
4 Analysts Have This to Say About Pacira BioSciences
August 03, 2023
Via
Benzinga
Analyst Ratings for Pacira BioSciences
July 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 26, 2023
On Tuesday, 386 stocks made new 52-week lows.
Via
Benzinga
Looking Into Pacira BioSciences's Return On Capital Employed
May 09, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
Monday's session saw 175 companies set new 52-week lows.
Via
Benzinga
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Recap: Pacira BioSciences Q1 Earnings
May 03, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Pacira BioSciences
April 20, 2023
Via
Benzinga
Analyst Expectations for Pacira BioSciences's Future
February 28, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 08, 2023
Friday's session saw 225 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
August 03, 2023
Via
Benzinga
Pacira BioSciences Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
July 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
May 09, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Why Pacira BioSciences Shares Are Trading Lower Today
May 03, 2023
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the
Via
Benzinga
Pacira BioSciences Reports First Quarter 2023 Financial Results
May 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
April 26, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
April 20, 2023
PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
April 19, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
April 03, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
March 29, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit
March 27, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors
March 22, 2023
From
Pacira BioSciences
Via
GlobeNewswire
Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference
March 08, 2023
From
Pacira BioSciences
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.